Evidence map›Paper›PMID 35774163›Full record

ArticleChemical science2022

A peptide-derived strategy for specifically targeting the mitochondria and ER of cancer cells: a new approach in fighting cancer.

Yang Sung Sohn, Anat Losub-Amir, Alfredo E Cardenas, Ola Karmi, Merav Darash Yahana, Tal Gruman, Linda Rowland, Henri-Baptiste Marjault, Lauren J Webb, Ron Mittler and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Yang Sung SohnThe Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel rachel@mail.huji.ac.il.ORCID https://orcid.org/0000-0001-6001-5253
Anat Losub-AmirInstitute of Chemistry, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel assaf.friedler@mail.huji.ac.il.
Alfredo E CardenasInstitute for Computational Engineering and Science and Department of Chemistry, University of Texas at Austin Austin Texas 78712 USA.ORCID https://orcid.org/0000-0002-9687-7979
Ola KarmiThe Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel rachel@mail.huji.ac.il.
Merav Darash YahanaThe Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel rachel@mail.huji.ac.il.
Tal GrumanInstitute of Chemistry, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel assaf.friedler@mail.huji.ac.il.
Linda RowlandDepartment of Surgery, University of Missouri School of Medicine, Christopher S. Bond Life Sciences Center University of Missouri. 1201 Rollins St Columbia MO 65201 USA.
Henri-Baptiste MarjaultThe Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel rachel@mail.huji.ac.il.
Lauren J WebbDepartment of Chemistry, The University of Texas at Austin 2506 Speedway STOP A5300 Austin TX 78712 USA.ORCID https://orcid.org/0000-0001-9999-5500
Ron MittlerDepartment of Surgery, University of Missouri School of Medicine, Christopher S. Bond Life Sciences Center University of Missouri. 1201 Rollins St Columbia MO 65201 USA.ORCID https://orcid.org/0000-0003-3192-7450
Ron ElberInstitute for Computational Engineering and Science and Department of Chemistry, University of Texas at Austin Austin Texas 78712 USA.ORCID https://orcid.org/0000-0001-7849-415X
Assaf FriedlerInstitute of Chemistry, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel assaf.friedler@mail.huji.ac.il.ORCID https://orcid.org/0000-0003-1592-1278
Rachel NechushtaiThe Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus at Givat Ram Jerusalem 9190401 Israel rachel@mail.huji.ac.il.ORCID https://orcid.org/0000-0002-3219-954X
Hebrew University of Jerusalem · ILThe University of Texas at Austin · USUniversity of Missouri · US

Funding

LONG TIME DYNAMICS OF BIOMOLECULESR01GM059796 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI ELBER, RON · 2000 to 2021
$5.7M
Modeling Membrane Dynamics and PermeationR01GM111364 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI CARDENAS, ALFREDO, ELBER, RON · 2016 to 2023
$2.5M
NIGMS NIH HHS R01 GM059796NIGMS NIH HHS R01 GM111364
6 · The paper itself

Abstract

An effective anti-cancer therapy should exclusively target cancer cells and trigger in them a broad spectrum of cell death pathways that will prevent avoidance. Here, we present a new approach in cancer therapy that specifically targets the mitochondria and ER of cancer cells. We developed a peptide derived from the flexible and transmembrane domains of the human protein NAF-1/CISD2. This peptide (NAF-1

Identifiers

PMID35774163
PMCPMC9200128
OpenAlexW4283780548

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.